Kripthonite Therapeutics is a preclinical biotech company that develops a therapy that eliminates oxygen-depleted cancer cells in solid tumors. Oxygen-depletion heightens the most aggressive features of cancers and results in resistance towards radiation and immuno- and chemotherapy. Our therapy derails energy metabolism in oxygen-depleted cancer cells, leading to rapid and selective cancer cell killing.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Agern Allé 24, Hørsholm,2970,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.kripthonite.com
- Keywords
- Complir.
- HQ
- Hørsholm
Kripthonite Therapeutics Questions
Kripthonite Therapeutics's website is http://www.kripthonite.com
Kripthonite Therapeutics's LinkedIn profile is https://dk.linkedin.com/company/kripthonite-therapeutics
Kripthonite Therapeutics has
4 employees.
View email and phone details for 4
employees at Kripthonite Therapeutics.
Kripthonite Therapeutics's industry is
Biotechnology Research
Kripthonite Therapeutics's top competitors are
Marigold Investment Management,
Complir,
Nordic Innovation Fair,
Reefcircular,
Sikr,
Remote.io,
Mmimetika Biosciences Aps,
Bclude,
Zyneyro,
Proem.
Kripthonite Therapeutics's categories are Biotechnology Research
Kripthonite Therapeutics's founding year is 2023
